Our Western blot analyses demonstrated that 3xTg-AD mice treated with 0.1 mg/kg TAC i.p. exhibited lower levels of tau and phosphorylated tau compared to vehicle-treated mice (Figure 5A–D). Here, MAPT is linked to Alzheimer disease.